Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

588 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2).
Nomoto H, Miyoshi H, Furumoto T, Oba K, Tsutsui H, Miyoshi A, Kondo T, Tsuchida K, Atsumi T, Manda N, Kurihara Y, Aoki S; SAIS Study Group. Nomoto H, et al. Among authors: miyoshi h, miyoshi a. PLoS One. 2015 Aug 18;10(8):e0135854. doi: 10.1371/journal.pone.0135854. eCollection 2015. PLoS One. 2015. PMID: 26284918 Free PMC article. Clinical Trial.
NETosis markers: Quest for specific, objective, and quantitative markers.
Masuda S, Nakazawa D, Shida H, Miyoshi A, Kusunoki Y, Tomaru U, Ishizu A. Masuda S, et al. Among authors: miyoshi a. Clin Chim Acta. 2016 Aug 1;459:89-93. doi: 10.1016/j.cca.2016.05.029. Epub 2016 May 31. Clin Chim Acta. 2016. PMID: 27259468 Free article. Review.
The Presence of Anti-Lactoferrin Antibodies in a Subgroup of Eosinophilic Granulomatosis with Polyangiitis Patients and Their Possible Contribution to Enhancement of Neutrophil Extracellular Trap Formation.
Shida H, Nakazawa D, Tateyama Y, Miyoshi A, Kusunoki Y, Hattanda F, Masuda S, Tomaru U, Kawakami T, Atsumi T, Ishizu A. Shida H, et al. Among authors: miyoshi a. Front Immunol. 2016 Dec 23;7:636. doi: 10.3389/fimmu.2016.00636. eCollection 2016. Front Immunol. 2016. PMID: 28066444 Free PMC article.
Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes.
Takahashi K, Cho KY, Nakamura A, Miya A, Miyoshi A, Yamamoto C, Nomoto H, Niwa H, Takahashi K, Manda N, Kurihara Y, Aoki S, Ito YM, Atsumi T, Miyoshi H. Takahashi K, et al. Among authors: miyoshi h, miyoshi a. J Diabetes Investig. 2019 Mar;10(2):429-438. doi: 10.1111/jdi.12913. Epub 2018 Sep 26. J Diabetes Investig. 2019. PMID: 30136403 Free PMC article.
Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis.
Miyoshi A, Kameda H, Nagai S, Nakamura A, Miya A, Takase T, Atsumi T, Miyoshi H. Miyoshi A, et al. Among authors: miyoshi h. J Diabetes Investig. 2021 Jul;12(7):1293-1300. doi: 10.1111/jdi.13458. Epub 2020 Dec 13. J Diabetes Investig. 2021. PMID: 33141482 Free PMC article.
588 results